Fund Low Barrier Buprenorphine Access

What You Need To Know

• Micro-dosing of buprenorphine allows someone to begin taking the medication without experiencing a painful withdrawal process first. This removes a huge barrier to care. 

• The first dose can also be given in a community setting such as an SSP, by a primary care physician, or in an emergency room. 

• Studies have shown that microinduction is better tolerated by patients and contributes to a decrease in people returning to illicit substance use.*  

• Medications for opioid use disorder (MOUD) are most effective when someone chooses to start treatment (versus being coerced or mandated).

Where to Go for More Information

• The Pharmacology of Buprenorphine Microinduction for Opioid Use Disorder

• Suboxone Treatment Across Transitions (duke.edu)

• Buprenorphine Dosage Instructions – CAMP (penncamp.org)

• Buprenorphine Microdose Induction for the Management of Prescription Opioid Dependence | American Board of Family Medicine (jabfm.org)

• Buprenorphine | Pain Management Education at UCSF

Research

• Rapid buprenorphine microdosing for opioid use disorder in a hospitalized patient receiving very high doses of full agonist opioids for acute pain management: Titration, implementation barriers, and strategies to overcomes - PubMed (nih.gov)